Showing results (1841-1850 of 1,952) with videos related to

Sort By:
Pageof 196
Haematologica|August 8, 2024
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemiaJanani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, et al.
American Journal of Human Genetics|November 24, 2020
Heterozygous Variants in KDM4B Lead to Global Developmental Delay and Neuroanatomical DefectsAnna R Duncan, Antonio Vitobello, Stephan C Collins, et al.
Astrobiology|October 23, 2018
The NASA Roadmap to Ocean WorldsAmanda R Hendrix, Terry A Hurford, Laura M Barge, et al.
Iscience|March 19, 2024
Comprehensive phylogeny of Pieridae butterflies reveals strong correlation between diversification and temperatureAna Paula S Carvalho, Hannah L Owens, Ryan A St Laurent, et al.
Genome Medicine|February 20, 2019
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesotheliomaRaunak Shrestha, Noushin Nabavi, Yen-Yi Lin, et al.
European Urology|March 24, 2017
Stromal Gene Expression is Predictive for Metastatic Primary Prostate CancerFan Mo, Dong Lin, Mandeep Takhar, et al.
The Journal of Pathology|February 2, 2012
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancerChunxiao Wu, Alexander W Wyatt, Anna V Lapuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2023
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 StudyIgnace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, et al.
Gynecologic Oncology|April 18, 2026
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 studyEls Van Nieuwenhuysen, Ignace Vergote, Leslie M Randall, et al.
Medrxiv : the Preprint Server for Health Sciences|May 9, 2025
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype StudyYen-Yi Lin, Hamideh Sharifi Noghabi, Stanislav Volik, et al.
Pageof 196